search
Back to results

Effectiveness of Enhanced Treatments for Drug Dependence (EETDD)

Primary Purpose

Cocaine Dependence

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Telephone Monitoring and Counseling - Enhanced
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cocaine Dependence

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • (1) qualify for a DSM-IV diagnosis of cocaine dependence, with some cocaine use in the prior 6 months;
  • (2) be 18 to 75 years of age;
  • (3) have no current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment;
  • (4) have no acute medical problem requiring immediate inpatient treatment;
  • (5) not be in methadone or other modes of Drug and Alcohol treatment, other than Intensive Outpatient Program;
  • (6) be willing to be randomized and participate in research;
  • (7) because of study follow-up requirements, subjects will be able to provide the name, verified telephone number, and address of at least one contact who can provide locator information on the patient during follow-up. We will include patients with dependence on other substances, provided that they are cocaine dependent and meet other inclusion criteria.

Exclusion Criteria:

  • have a current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment;
  • have acute medical problem requiring immediate inpatient treatment;
  • are in methadone or other modes of DA treatment, other than IOP;
  • or cannot provide names of people who can get messages to them for follow up, in the event we cannot locate the participant at their original address and number. Also, if they are court mandated to treatment or otherwise considered a prisoner, they will be ineligible for the study as we have not applied for Subpart C approval.

Sites / Locations

  • University of Pennsylvania

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

TAU

Counseling (TMAC-E)

Arm Description

This group is the control group by which we are comparing our intervention. This group will not receive an intervention from us but will continue to be treated at the Intensive Outpatient facility from which we recruited them.

This telephone based intervention includes six factors to improve our extended treatment model: Incentive component; Patient choice; Provision of cell phones to those who need them; Social support and community resources; Positive recovery factors; and Outreach following dropout.

Outcomes

Primary Outcome Measures

Time Line Follow Back
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
Time Line Follow Back
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
Time Line Follow Back
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
Time Line Follow Back
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)

Secondary Outcome Measures

Full Information

First Posted
June 24, 2010
Last Updated
March 28, 2017
Sponsor
University of Pennsylvania
search

1. Study Identification

Unique Protocol Identification Number
NCT01153477
Brief Title
Effectiveness of Enhanced Treatments for Drug Dependence
Acronym
EETDD
Official Title
Effectiveness of an Enhanced Adaptive Continuing Care Model for Cocaine Dependence
Study Type
Interventional

2. Study Status

Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
October 2009 (undefined)
Primary Completion Date
October 2011 (Actual)
Study Completion Date
October 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pennsylvania

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this challenge grant is to conduct an initial test of a new, enhanced version of this protocol (telephone monitoring and counseling - enhanced, or TMAC-E), which has been modified to include the elements of our existing continuing care intervention plus patient-centered changes to boost patient involvement and community linkages. The investigators will recruit 150 cocaine dependent patients in publicly funded, community-based programs and randomize them to treatment as usual or the TMAC-E and follow them for 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine Dependence

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TAU
Arm Type
No Intervention
Arm Description
This group is the control group by which we are comparing our intervention. This group will not receive an intervention from us but will continue to be treated at the Intensive Outpatient facility from which we recruited them.
Arm Title
Counseling (TMAC-E)
Arm Type
Experimental
Arm Description
This telephone based intervention includes six factors to improve our extended treatment model: Incentive component; Patient choice; Provision of cell phones to those who need them; Social support and community resources; Positive recovery factors; and Outreach following dropout.
Intervention Type
Behavioral
Intervention Name(s)
Telephone Monitoring and Counseling - Enhanced
Intervention Description
Calls or in-person sessions, 1x weekly for first 8 weeks, then every other week up to a year. Step up session frequency if needed based on participants' ratio of protective and risk factors.
Primary Outcome Measure Information:
Title
Time Line Follow Back
Description
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
Time Frame
3 month
Title
Time Line Follow Back
Description
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
Time Frame
6 month
Title
Time Line Follow Back
Description
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
Time Frame
9 month
Title
Time Line Follow Back
Description
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
Time Frame
12 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: (1) qualify for a DSM-IV diagnosis of cocaine dependence, with some cocaine use in the prior 6 months; (2) be 18 to 75 years of age; (3) have no current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment; (4) have no acute medical problem requiring immediate inpatient treatment; (5) not be in methadone or other modes of Drug and Alcohol treatment, other than Intensive Outpatient Program; (6) be willing to be randomized and participate in research; (7) because of study follow-up requirements, subjects will be able to provide the name, verified telephone number, and address of at least one contact who can provide locator information on the patient during follow-up. We will include patients with dependence on other substances, provided that they are cocaine dependent and meet other inclusion criteria. Exclusion Criteria: have a current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment; have acute medical problem requiring immediate inpatient treatment; are in methadone or other modes of DA treatment, other than IOP; or cannot provide names of people who can get messages to them for follow up, in the event we cannot locate the participant at their original address and number. Also, if they are court mandated to treatment or otherwise considered a prisoner, they will be ineligible for the study as we have not applied for Subpart C approval.
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Effectiveness of Enhanced Treatments for Drug Dependence

We'll reach out to this number within 24 hrs